Intra-Cellular Launches New Bipolar Ad Campaign for Calypta
Intra-Cellular’s schizophrenia drug Calypta has recently gained FDA approval for bipolar depression. In response, the company has launched a aggressive [...]
Advertisement
Intra-Cellular’s schizophrenia drug Calypta has recently gained FDA approval for bipolar depression. In response, the company has launched a aggressive [...]
